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Abstract 
 
The reaction of 2-(2H-tetrazol-5-yl)pyridine (L1) with 1,n-dibromoalkane (n = 3, 4, 6 or 8) 
results in the formation of the isomers 2-(n′′-bromoalkyl-(1-tetrazol-5-yl)pyridine (L2A-D) 
and 2-(n′′-bromoalkyl-(2-tetrazol-5-yl)pyridine (L3A-D). The reaction of L1 with 1-
bromoalkanes also resulted in the formation of isomeric materials, namely 2-(n′′-alkyl-(1-
tetrazol-5-yl)pyridine (L4A-C) and 2-(n′′-alkyl-(2-tetrazol-5-yl)pyridine (L5A-C). 
Complexation reactions of these ligands with the transition metal salts CuCl2.2H2O, 
Co(NCS)2, NiCl2.2H2O and ZnCl2 were carried out in methanol and resulted in complexes 
containing a 1:1 metal:ligand stoichiometry except in the cases of the cobalt complexes 
where a 1:2 metal:ligand stoichiometry was obtained. The 
1
H NMR spectra of the zinc 
complexes showed that the ligands containing the pendant arm in the 2-N position of the 
tetrazole ring bind the zinc ion more strongly than those containing the pendant arm in the 1-
N position. The X-ray structures of two cobalt salts, Co(L5A)2(NCS)2 and Co(L5C)2(NCS)2, 
are also discussed. 
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Introduction 
 
The development of “click” chemistry, as described by Sharpless and co-workers [1-2], has 
resulted in a recent increase in the synthesis of functional compounds containing polyazole 
rings, particularly triazoles, tetrazoles and their derivatives [3-7]. Tetrazoles have been 
recognised as bioisosteres for carboxylic acids and as a result have found widespread 
applications in medicinal chemistry [3]. Tetrazoles and its derivatives have also been studied 
as ligands in coordination chemistry, exhibiting several coordination modes [8]. Our interest 
in tetrazoles concerns their use in molecular recognition. We have previously reported the 
synthesis of various bis- and tetra-tetrazole molecules [9]. To expand this area, we are 
currently investigating the use of tetrazole-containing compounds as potential metal-based 
therapeutic agents, especially as anti-cancer or anti-fungicidal agents. Recently, we have 
described the synthesis of some pyridyl-tetrazole compounds containing bromohexyl pendant 
arms and examined their coordination chemistry with Fe(II), Co(II) and Cu(II) salts, a range 
of metal cations which the human body can tolerate [10]. As part of our current investigations 
into the coordination chemistry of pyridyl-tetrazole derivatives, we have altered the pendant 
arm extending from the tetrazole ring to include other alkyl bromide chains as well as alkyl 
chain on their own (see Scheme 1). In this paper, we describe the synthesis of pyridyl-
tetrazole compounds containing other bromoalkyl and alkyl pendant arms and examine the 
coordination chemistry of these tetrazole derivatives with the transition-metal salts 
CuCl2.2H2O, Co(NCS)2, NiCl2.2H2O and ZnCl2 and also the crystal structures of two 
cobalt(II) complexes. 
 
Results and Discussion 
 
Ligand synthesis 
 
The reaction of 2-(2H-tetrazol-5-yl)pyridine (L1) with either the appropriate 1,n-
dibromoalkanes (n = 3, 4, 6 or 8) or bromoalkane in acetonitrile with potassium carbonate as 
base resulted in the formation of either 2-(n’’-bromoalkyl-(1-tetrazol-5-yl)pyridine (L2A-D) 
and 2-(n’’-bromoalkyl-(2-tetrazol-5-yl)pyridine (L3A-D) or 2-(alkyl-(1-tetrazol-5-yl)pyridine 
(L4A-C) and 2-(alkyl-(2-tetrazol-5-yl)pyridine (L5A-C), arising from alkylation at either the 
1-N or 2-N positions, in a manner similar to that described in the literature [10], as shown in 
Scheme 1. Column chromatography was used to separate the isomeric products. In all cases, 
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the loss of the CH2Br signal in the 
1
H NMR spectra of the products and the appearance of a 
triplet at ~5.00 ppm for the 1-N compounds or ~4.80 ppm for the 2-N compounds was taken 
as evidence for the formation of the products. The isomers are readily distinguishable by their 
13
C NMR spectra with the 
13
C NMR chemical shift of the tetrazole carbon atom appearing at 
ca. 154.0 or 164.0 ppm in the 1,5- and 2,5-disubstituted tetrazoles, respectively [9f,11]. In 
these reactions, the 1-N isomers (L2A-D and L4A-C) gave a signal at ~151 ppm, while the 2-
N isomers (L3A-D and L5A-C) gave a signal at ~164 ppm.  
 
 
 
Scheme 1 Reaction conditions: i) 1,n-dibromoalkane (n = 3, 4, 6 or 8) or 1-RBr (R = C4H9, 
C6H13 or C8H17), K2CO3, MeCN, Δ, 24 hr; L2/L3 A: R = C3H6Br, B: R = C4H8Br, C: R = 
C6H12Br, D: R = C8H16Br; L4/L5 A: R = C4H9, B: R = C6H13, C: R = C8H17. 
 
Coordination Reactions 
 
The transition-metal salts CuCl2.2H2O, Co(NCS)2, NiCl2.6H2O and ZnCl2 were reacted with 
L2A-D, L3A-D, L4A-C and L5A-C, respectively, in methanol at reflux temperature under 
an inert atmosphere for two hours. The reactions with the cobalt salt were only carried out 
with the L4 and L5 derivatives. The chloride salts of copper, nickel and zinc were used since 
the structures of the L2C and L3C ligands with copper chloride has previously shown the 
formation of halide bridging [14] and it was felt that similar structures would be observed 
with these metal chloride salts. All reactions were carried out using a 1:1 metal to ligand 
stoichiometry. The resulting solutions were allowed to stand for several days, after which 
time the solid products were filtered. All the copper and nickel complexes of the L2 and L3 
ligands were green in colour, while the zinc complexes were either pale orange or cream, 
which was the colour of the starting ligand. The copper and nickel reactions with the L4 and 
L5 derivatives also resulted in green solids being formed, while the cobalt complexes yielded 
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green solids in the cases of the 1-N derivatives and rust coloured solids in the cases of the 2-N 
derivatives. The zinc complexes were either yellow or brown in colour, which was the colour 
of the starting tetrazole derivative. Elemental analyses on all of the copper, nickel and zinc 
products obtained showed that all the complexes have a 1:1 metal:ligand composition. Based 
on the X-ray structures of [Cu(L2C)Cl2]2 and [Cu(L3C)Cl2]2 previously reported [10] which 
contained a 1:1 metal:ligand composition and also a dichloro-bridged dimeric {Cu(II)(μ-
Cl)Cl}2 unit, it is proposed that all the metal chloride complexes synthesised herein will have 
a similar structure, as shown in Figure 1.   
 
 
 
Figure 1 Proposed structures for all metal complexes (M = Cu, Ni or Zn; R = C3H6Br, 
C4H8Br, C6H12Br, C8H16Br, C4H9, C6H13 or C8H17). 
 
The cobalt complexes of the L4 and L5 derivatives were shown to have a 1:2 metal to ligand 
composition. We have previously reported the X-ray structures of the cobalt(II) 
isothiocyanate complexes of 2-(6’’-bromohexyl-(1-tetrazol-5-yl)pyridine (L2C) and 2-(6’’-
bromohexyl-(2-tetrazol-5-yl)pyridine (L3C) [10], both of which contained a 1:2 metal to 
ligand composition. We were able to grow crystals of both Co(5A)2(NCS)2 and 
Co(5C)2(NCS)2 from methanol, which were suitable for X-ray structural studies, and so can 
compare these structures. 
 
Magnetic measurements 
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All of the copper complexes have a magnetic moment in the range of 2.1-2.4 B.M., which is 
indicative of the presence of copper(II) in the complexes. The magnetic moments for the 
nickel complexes are between 2.9 and 4.1 B.M. These values are high for either four 
coordinate tetrahedral geometry or five coordinate trigonal bipyramidal geometry at the 
nickel centre. The magnetic measurements of the cobalt(II) complexes indicated the presence 
of high-spin cobalt(II) ions. Previously reported magnetic moments for complexes containing 
pyridyl-tetrazole ligands have been high in value and high-spin in nature [10,12]. 
 
1
H NMR spectra 
 
The 
1
H NMR spectra of the zinc chloride complexes of the ligands L2A-D and L3A-D were 
all obtained in CDCl3. Table 1 shows the 
1
H NMR spectral data for the four pyridyl-tetrazole 
ligands with the alkyl bromides attached at the 1-N position (L2A-D) and the four 
corresponding zinc chloride complexes while Table 2 contains the 
1
H NMR spectral data for 
the four pyridyl-tetrazole ligands with the alkyl bromides attached at the 2-N position (L3A-
D) and the four corresponding zinc chloride complexes.  
 
Table 1. 
Selected 
1
H NMR data for the ligands L2A-D and their ZnCl2 complexes.
a
  
 
Compound pyr-H
 
pyr-H pyr-H pyr-H CH2N 
L2A 8.75 8.37 7.93 7.47 5.15 
[Zn(L2A)Cl2]2 8.78 8.35 7.95 7.45 5.18 
L2B 8.74 8.37 7.93 7.47 5.04 
[Zn(L2B)Cl2]2 8.78 8.36 7.96 7.50 5.02 
L2C
b 
8.77 8.37 7.96 7.52 5.00 
[Zn(L2C)Cl2]2 8.92 8.29 8.06 7.61 4.92 
L2D 8.73 8.37 7.90 7.45 4.98 
[Zn(L2D)Cl2]2 8.76 8.32 7.97 7.49 4.96 
a
: obtained in CDCl3  
b
: data from reference 14 
 
Table 2. 
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Selected 
1
H NMR data for the ligands L3A-D and their ZnCl2 complexes.
a
  
 
Compound pyr-H
 
pyr-H pyr-H pyr-H CH2N 
L3A 8.78 8.26 7.87 7.41 4.91 
[Zn(L3A)Cl2]2 8.88 8.31 8.16 7.60 5.01 
L3B 8.78 8.25 7.87 7.40 4.77 
[Zn(L3B)Cl2]2 8.96 8.29 8.22 7.84 4.88 
L3C
b 
8.80 8.27 7.90 7.43 4.73 
[Zn(L3C)Cl2]2 8.86 8.28 8.19 7.76 4.81 
L3D 8.79 8.25 7.87 7.40 4.70 
[Zn(L3D)Cl2]2 8.89 8.31 8.22 7.81 4.81 
a
: obtained in CDCl3  
b
: data from reference 14 
 
From the data in Tables 1 and 2, it is evident that stronger binding of the zinc chloride occurs 
with the series of ligands L3A-D, which contain the alkyl bromide at the 2-N position, as 
seen from the larger differences in chemical shift for both the pyridyl proton signals and the 
signal for the methylene group attached to the tetrazole ring. The spectra of the zinc 
complexes from the L2A-D series of ligands shows only slight variation in signal position 
compared to the starting ligands. It is not obvious why the position of the pendant arm on the 
tetrazole ring (1-N or 2-N) should have such a bearing on the signals in the 
1
H NMR spectra 
of the zinc chloride complexes, especially since the metal ion is believed to coordinate to the 
pyridine nitrogen atom and one tetrazole nitrogen atom to form a five-membered ring, as 
depicted in Figure 1. In the crystal structure of [Cu(L2C)Cl2]2, the two bromohexyl arms are 
above and below the central Cu2Cl2 core and are also pointing away from the core, while in 
the crystal structure of [Cu(L3C)Cl2]2 both arms point in the same direction but again away 
from the central core [14]. Furthermore, if the pendant arm was in some way blocking the 
binding site, then it would be expected that the longer length arms would be more influential 
in this regard than the shorter length chains, but this does not appear to be the case. Further 
studies, including computational studies, are currently being undertaken in order to try to 
elucidate the reason for the regiochemical differences in binding strengths. The 
1
H NMR 
spectra of the zinc chloride complexes of the ligands L4A-C and L5A-C were also obtained 
in CDCl3. The spectral data was in agreement with the proposed binding of the zinc ion to the 
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pyridyl nitrogen atom and one of the tetrazole nitrogen atoms, as can be seen from the shift in 
the signals associated with the pyridine ring and also the methylene group bonded to the 
tetrazole ring. 
 
X-ray structures of Co(L5A)2(NCS)2 and Co(L5C)2(NCS)2  
 
The molecular structures for Co(L5A)2(NCS)2 and Co(L5C)2(NCS)2 (with the cobalt atom 
residing on inversion centres) are depicted in Figures 2 and 3, respectively. Crystallographic 
information is detailed in Table 3. In both structures, the cobalt(II) atom has an octahedral 
coordination geometry with the pyridyl-tetrazole L5A and L5C ligands chelating in the 
equatorial plane and with the two isothiocyanate anions coordinating along the axial 
direction. Each pyridyl-tetrazole ligand binds to the cobalt(II) ion through one tetrazole 
nitrogen atom at the 1-N site and through the pyridyl nitrogen atom. As previously observed 
[10], the pyridine rings are not coplanar with the tetrazole rings and so both complexes 
display a slightly puckered conformation. The planes between the pyridine and tetrazole rings 
form interplanar angles of 3.8(5)° and 1.6(5)° in Co(L5A)2(NCS)2 and 4.5(4)° in 
Co(L5C)2(NCS)2. The Co-NNCS distances are in the range from 2.037(6) to 2.060(6) Å, 
whereas the remaining Co-N distances are 0.10 Å longer and in the range 2.140(4) to 
2.170(3) Å. These bond lengths are typical of Co
II
-N distances involving isothiocyanate and 
heteroaromatic ring donor groups from an analysis of the Cambridge Structural Database. 
The isothiocyanate moieties in both complexes are regular with NCS angles of 178.5(6), 
176.9(5) and 178.5(4). The coordination geometry is close to ideal octahedral in 
Co(L5A)2(NCS)2 with all three trans angles within 1 of 180 [range from 179.3(2) to 
179.9(3)], whereas, Co(L5C)2(NCS)2 resides with the cobalt atom on inversion centres and 
trans N-Co-N angles of 180. There are no classical hydrogen bonds in either structures and 
aggregation is by weak interactions and contacts. 
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Figure 2. A view of Co(L5A)2(NCS)2 with atoms depicted with displacement ellipsoids at 
their 20% probability level. 
 
 
Figure 3. A view of Co(L5C)2(NCS)2 with atoms depicted with displacement ellipsoids at the 
20% probability level; only one component of the disordered n-octyl chain is shown. 
 
Table 3.  
Crystallographic Data for Co(L5A)2(NCS)2 and Co(L5C)2(NCS)2  
 
 Co(L5A)2(NCS)2 Co(L5C)2(NCS)2 
Formula C22H26CoN12S2 C30H42CoN12S2 
M/g mol
–1
 581.60 693.81 
9 
 
Crystal system Orthorhombic Monoclinic 
Space group Pca21 P21/c 
T/K 294(1) 294(1) 
a/Å 15.9466(4) 13.5506(10) 
b/Å 8.4530(2) 8.4428(5) 
c/Å 20.6129(5) 15.9122(10) 
α/° 90 90 
β/° 90 99.063(7) 
γ/° 90 90 
V/Å
3
 2778.55(12) 1797.7(2) 
Z 4 2 
Dc/g cm
-3
 1.39 1.282 
Reflections collected 14564 17401 
Unique reflections 5529 4759 
Rint 0.026 0.046 
Obs. reflections [I > 2(I)] 4007 3108 
No. of parameters 337 224 
No. of restraints 37 5 
R1 [I > 2(I)] 0.052 0.080 
wR2 (all data) 0.132 0.199 
GoF 1.036 1.116 
 
Experimental 
 
1
H and 
13
C NMR (δ ppm; J Hz) spectra were recorded on a Bruker Avance 300 MHz NMR 
spectrometer using saturated CDCl3 solutions with Me4Si reference, unless indicated 
otherwise, with resolutions of 0.18 Hz and 0.01 ppm, respectively. Infrared spectra (cm
-1
) 
were recorded as KBr discs using a Perkin Elmer System 2000 FT-IR spectrometer. UV-vis 
spectra were recorded using a Unicam UV 540 spectrometer. Melting point analyses were 
carried out using a Stewart Scientific SMP 1 melting point apparatus and are uncorrected. 
Electrospray (ESI) mass spectra were collected on an Agilent Technologies 6410 Time of 
Flight LC/MS. Compounds were dissolved in acetonitrile-water (1:1) solutions containing 
0.1% formic acid, unless otherwise stated.  The interpretation of mass spectra was made with 
the help of the program “Agilent Masshunter Workstation Software”. Magnetic susceptibility 
measurements were carried out at room temperature using a Johnson Matthey Magnetic 
Susceptibility Balance with [HgCo(SCN)4] as reference. Microanalyses were carried out at 
the Microanalytical Laboratory of the National University of Ireland Maynooth. Standard 
Schlenk techniques were used throughout. Starting materials were commercially obtained and 
used without further purification. The compound 2-(2H-tetrazol-5-yl)pyridine (L1), the 
bromohexyl derivatives 2-(6’’-bromoalkyl-(1-tetrazol-5-yl)pyridine (L2C) and 2-(6’’-
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bromoalkyl-(2-tetrazol-5-yl)pyridine (L3C) as well as the copper complexes [Cu(L2C)Cl2]2 
and [Cu(L3C)Cl2]2 have been reported previously [10]. 
Caution! Nitrogen-rich compounds such as tetrazole derivatives are used as components for 
explosive mixtures [13]. In our laboratory, the reactions described were run on a few gram 
scale, and no problems were encountered. However, great caution should be exercised when 
heating or handling compounds of this type.  
 
General synthesis of 2-(n’’-bromoalkyl-(1-tetrazol-5-yl)pyridine (L2) and 2-(n’’-bromoalkyl-
(2-tetrazol-5-yl)pyridine (L3) 
 
To L1 (2.00 g, 13.6 mmol) dissolved in acetonitrile (60 mL) was added potassium carbonate 
(18.8 g, 136 mmol). The resulting solution was heated at reflux temperature for 30 minutes 
and to the hot solution was added 1,n-dibromoalkane (48.0 mmol, n = 3, 4, 6 or 8). The 
reaction mixture was then stirred at reflux temperature for a further 24 h. After cooling, the 
inorganic solids were removed by filtration and the solvent was removed under reduced 
pressure to afford an oil, which was purified by column chromatography on silica gel 
(initially at a ratio of petroleum ether:ethyl acetate 80:20, followed by the ratio of 60:40). 
This gave the products L2A-D and L3A-D. 
 
L2A: Dark brown solid (0.46 g, 13 %). m.p. 190-192 °C. C9H10N5Br: calcd. C 40.32, H 3.76, 
N 26.12; found C 39.99, H 3.88, N 25.89. IR (KBr): υ = 2980, 2909, 1624, 1586, 1502, 1447, 
1374, 1301, 1166, 1140, 971, 799, 720 cm
-1
. 
1
H NMR (CDCl3): δ = 8.75 (m, 1H, pyr-H), 8.37 
(m, 1H, pyr-H), 7.93 (m, 1H, pyr-H), 7.47 (m, 1H, pyr-H), 5.15 (t, 2H, J = 6.8 Hz, CH2N), 
3.47 (t, 2H, J = 6.4 Hz, CH2Br), 2.57 (m, 2H, CH2) ppm. 
13
C NMR (CDCl3): δ = 151.8 
(CN4), 149.5, 144.7, 137.5, 125.4, 124.5, 48.2 (CH2N), 34.8 (CH2Br), 31.1 ppm. ESI-HRMS: 
calcd for C9H11N5Br [M+1]
+
  268.0192, found 268.0188. 
 
L3A: Waxy orange solid (1.38 g, 38 %). m.p. 158-160 °C. C9H10N5Br: calcd. C 40.32, H 
3.76, N 26.12; found C 39.98, H 3.71, N 25.88. IR (KBr): υ = 2980, 2931, 1623, 1589, 1533, 
1469, 1432, 1357, 1283, 1119, 1042, 993, 799, 740 cm
-1
. 
1
H NMR (CDCl3): δ = 8.78 (m, 1H, 
pyr-H), 8.26 (m, 1H, pyr-H), 7.87 (m, 1H, pyr-H), 7.41 (m, 1H, pyr-H), 4.91 (t, 2H, J = 6.7 
Hz, CH2N), 3.46 (t, 2H, J = 6.2 Hz, CH2Br), 2.65 (m, 2 H, CH2) ppm. 
13
C NMR (CDCl3): δ = 
164.9 (CN4), 150.3, 146.6, 137.4, 124.9, 122.4, 51.5 (CH2N), 31.8 (CH2Br), 28.7 ppm. ESI-
HRMS: calcd for C9H11N5Br [M+1]
+
  268.0192, found 268.0196.  
11 
 
 
L2B: Waxy brown solid (0.86 g, 23 %). m.p. 41-45 °C. C10H12N5Br: calcd. C 42.57, H 4.29, 
N 24.82; found C 42.51, H 4.30, N 24.77. IR (KBr): υ = 2958, 2865, 1590, 1530, 1471, 1432, 
1403, 1330, 1277, 1122, 1092, 993, 796, 742 cm
-1
. 
1
H NMR (CDCl3): δ = 8.74 (m, 1H, pyr-
H), 8.37 (m, 1H, pyr-H), 7.93 (m, 1H, pyr-H), 7.47 (m, 1H, pyr-H), 5.04 (t, 2H, J = 7.0 Hz, 
CH2N), 3.44 (t, 2H, J = 6.2 Hz, CH2Br), 2.15 (m, 2H, CH2), 1.94 (m, 2H, CH2) ppm. 
13
C 
NMR (CDCl3): δ = 151.7 (CN4), 149.5, 144.9, 137.5, 125.3, 124.6, 48.6 (CH2N), 32.5 
(CH2Br), 30.9, 29.2 ppm. ESI-HRMS: calcd for C10H13N5Br [M+1]
+
  282.0349, found 
282.0352.  
 
L3B: Waxy brown solid (0.62 g, 16 %). m.p. 34-36 °C. C10H12N5Br: calcd. C 42.57, H 4.29, 
N 24.82; found C 42.51, H 4.42, N 25.01. IR (KBr): υ = 2942, 2866, 1624, 1586, 1456, 1434, 
1350, 1292, 1164, 1050, 1010, 792, 750 cm
-1
. 
1
H NMR (CDCl3): δ = 8.78 (m, 1H, pyr-H), 
8.25 (m, 1H, pyr-H), 7.87 (m, 1H, pyr-H), 7.40 (m, 1H, pyr-H), 4.77 (t, 2H, J = 6.8 Hz, 
CH2N), 3.44 (t, 2H, J = 6.4 Hz, CH2Br), 2.29 (m, 2H, CH2), 1.95 (m, 2H, CH2) ppm. 
13
C 
NMR (CDCl3): δ = 164.9 (CN4), 150.3, 146.8, 137.1, 124.8, 122.4, 52.4 (CH2N), 32.1 
(CH2Br), 29.2, 27.8 ppm. ESI-HRMS: calcd for C10H13N5Br [M+1]
+
 282.0349, found 
282.0350.  
 
L2D: Waxy orange solid (0.77 g, 17 %). m.p. 41-44 °C. C14H20N5Br: calcd. C 49.71, H 5.96, 
N 20.70; found C 49.72, H 5.85, N 20.37. IR (KBr): υ = 2937, 2860, 1613, 1593, 1467, 1433, 
1417, 1354, 1150, 1091, 1043, 991, 803, 747 cm
-1
. 
1
H NMR (CDCl3): δ = 8.73 (m, 1H, pyr-
H), 8.37 (m, 1H, pyr-H), 7.90 (m, 1H, pyr-H), 7.45 (m, 1H, pyr-H), 4.98 (t, 2H, J = 7.2 Hz, 
CH2N), 3.39 (t, 2H, J = 6.9 Hz, CH2Br), 1.96 (m, 2H, CH2), 1.80 (m, 2H, CH2), 1.30 (m, 8H, 
CH2) ppm. 
13
C NMR (CDCl3): δ = 151.5 (CN4), 149.4, 145.1 137.4, 125.2, 124.6, 49.5 
(CH2N), 33.9 (CH2Br), 32.9, 29.8, 28.7, 28.4, 27.9, 26.1 ppm. ESI-HRMS: calcd for 
C14H21N5Br [M+1]
+
  338.0975, found 338.0990.  
 
L3D: Waxy orange solid (0.86 g, 19 %). m.p. 41-50 °C. C14H20N5Br: calcd. C 49.71, H 5.96, 
N 20.70; found C 49.60, H 5.48, N 19.67. IR (KBr): υ = 2931, 2852, 1620, 1593, 1466, 1435, 
1416, 1351, 1149, 1092, 1042, 989, 803, 746 cm
-1
. 
1
H NMR (CDCl3): δ = 8.79 (m, 1H, pyr-
H), 8.25 (m, 1H, pyr-H), 7.87 (m, 1H, pyr-H), 7.40 (m, 1H, pyr-H), 4.70 (t, 2H, J = 7.1 Hz, 
CH2N), 3.39 (t, 2H, J = 6.8 Hz, CH2Br), 2.08 (m, 2H, CH2), 1.83 (m, 2H, CH2), 1.36 (m, 8H, 
CH2) ppm. 
13
C NMR (CDCl3): δ = 164.7 (CN4), 150.3, 146.9, 137.1, 124.7, 122.3, 53.4 
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(CH2N), 33.8 (CH2Br), 32.6, 29.2, 28.6, 28.4, 27.9, 26.2 ppm. ESI-HRMS: calcd for 
C14H21N5BrK [M+K]
+
  376.0534, found 376.0545.  
 
General synthesis of 2-(alkyl-(1-tetrazol-5-yl)pyridine (L4) and 2-(alkyl-(2-tetrazol-5-
yl)pyridine (L5) 
 
To L1 (2.00 g, 13.6 mmol) dissolved in acetonitrile (60 mL) was added potassium carbonate 
(18.8 g, 136 mmol). The resulting solution was refluxed for 30 minutes and to the hot 
solution was added Br(CH2)nCH3 (48.0 mmol, n = 3, 5 or 7). The reaction mixture was then 
stirred at reflux temperature for a further 24 h. After cooling, the inorganic solids were 
removed by filtration and the solvent was removed under reduced pressure to afford an oil, 
which was purified by column chromatography on silica gel (initially at a ratio of petroleum 
ether : ethyl acetate 80:20, followed by the ratio of 60:40). This gave the products L4A-C and 
L5A-C. 
 
2-(1-butyl-1H-tetrazol-5-yl)pyridine (L4A): 
 
Brown oil (0.85 g, 31 %). IR (neat): υ = 2961, 2934, 2874, 1591, 1571, 1532, 1471, 1433, 
1409, 1380, 1287, 1121, 1085, 1037, 994, 798, 744 cm
-1
. 
1
H NMR (CDCl3): δ = 8.73 (m, 1 H, 
pyr-H), 8.36 (m, 1 H, pyr-H), 7.91 (m, 1 H, pyr-H), 7.45 (m, 1 H, pyr-H), 4.99 (t, 2 H, J = 7.3 
Hz, CH2N), 1.94 (m, 2 H, CH2), 1.39 (m, 2 H, CH2), 0.95 (t, 3 H, J = 7.3 Hz, CH3) ppm. 
13
C 
NMR (CDCl3): δ = 151.7 (CN4), 149.4, 145.1, 137.4, 125.2, 124.6, 49.4 (CH2N), 31.9, 19.5, 
13.4 ppm. ESI-HRMS: calcd for C10H13N5Na [M+Na]
+
 226.1069, found 226.1063. 
 
2-(2-butyl-2H-tetrazol-5-yl)pyridine (L5A):  
 
Yellow oil (0.61 g, 22 %). IR (neat): υ = 2961, 2935, 2874, 1594, 1571, 1466, 1432, 1419, 
1387, 1356, 1156, 1043, 804, 747 cm
-1
. 
1
H NMR (CDCl3): δ = 8.79 (m, 1 H, pyr-H), 8.25 (m, 
1 H, pyr-H), 7.86 (m, 1 H, pyr-H), 7.39 (m, 1 H, pyr-H), 4.71 (t, 2 H, J = 7.1 Hz, CH2N), 2.07 
(m, 2 H, CH2), 1.41 (m, 2 H, CH2), 0.97 (t, 3 H, J = 7.3 Hz, CH3) ppm. 
13
C NMR (CDCl3): δ 
= 164.7 (CN4), 150.3, 146.9, 137.0, 124.7, 122.3, 53.2 (CH2N), 31.3, 19.6, 13.3 ppm. ESI-
HRMS: calcd for C10H14N5 [M+1]
+
 204.1244, found 204.1248. 
 
2-(1-hexyl-1H-tetrazol-5-yl)pyridine (L4B): 
13 
 
 
Brown oil (0.43 g, 14 %). IR (neat): υ = 2987, 2929, 2858, 2305, 1592, 1434, 1421, 1265, 
896, 744, 705 cm
-1
. 
1
H NMR (CDCl3): δ = 8.72 (m, 1 H, pyr-H), 8.36 (m, 1 H, pyr-H), 7.90 
(m, 1 H, pyr-H), 7.44 (m, 1 H, pyr-H), 4.97 (t, 2 H, J = 7.3 Hz, CH2N), 1.95 (m, 2 H, CH2), 
1.30 (m, 6 H, CH2), 0.87 (t, 3 H, J = 7.1 Hz, CH3) ppm. 
13
C NMR (CDCl3): δ = 151.6 (CN4), 
149.4, 145.1, 137.4, 125.2, 124.5, 49.6 (CH2N), 31.1, 29.8, 25.9, 22.3, 13.9 ppm. ESI-HRMS: 
calcd for C12H18N5 [M+1]
+
 232.1557, found 232.1557. 
 
2-(2-hexyl-2H-tetrazol-5-yl)pyridine (L5B): 
 
Yellow oil (0.54 g, 17 %). IR (neat): υ = 2957, 2929, 2858, 2305, 1595, 1466, 1434, 1420, 
1265, 802, 738, 704 cm
-1
. 
1
H NMR (CDCl3): δ = 8.79 (m, 1 H, pyr-H), 8.26 (m, 1 H, pyr-H), 
7.86 (m, 1 H, pyr-H), 7.40 (m, 1 H, pyr-H), 4.70 (t, 2 H, J = 7.2 Hz, CH2N), 2.12 (m, 2 H, 
CH2), 1.29 (m, 6 H, CH2), 0.88 (t, 3 H, J = 7.1 Hz, CH3) ppm. 
13
C NMR (CDCl3): δ = 164.7 
(CN4), 150.3, 146.9, 137.0, 124.7, 122.3, 53.5 (CH2N), 31.0, 29.3, 26.0, 22.3, 13.9 ppm. ESI-
HRMS: calcd for C12H18N5 [M+1]
+
 232.1557, found 232.1568. 
 
2-(1-octyl-1H-tetrazol-5-yl)pyridine (L4C): 
 
Brown oil (0.82 g, 23 %). IR (neat): υ = 2956, 2927, 2856, 1591, 1467, 1433, 1377, 1120, 
1036, 797, 743, 730 cm
-1
. 
1
H NMR (CDCl3): δ = 8.73 (m, 1 H, pyr-H), 8.36 (m, 1 H, pyr-H), 
7.90 (m, 1 H, pyr-H), 7.45 (m, 1 H, pyr-H), 4.97 (t, 2 H, J = 7.3 Hz, CH2N), 1.92 (m, 2 H, 
CH2), 1.27 (m, 10 H, CH2), 0.86 (t, 3 H, J = 6.9 Hz, CH3) ppm. 
13
C NMR (CDCl3): δ = 151.6 
(CN4), 149.4, 145.1, 137.3, 125.2, 124.5, 49.6 (CH2N), 31.7, 29.8, 29.1, 28.9, 26.2, 22.5, 14.0 
ppm. ESI-HRMS: calcd for C14H22N5 [M+1]
+
 260.1870, found 260.1881. 
 
2-(2-octyl-2H-tetrazol-5-yl)pyridine (L5C): 
 
Yellow oil (0.76 g, 22 %). IR (neat): υ = 2985, 2927, 2856, 1593, 1571, 1522, 1466, 1432, 
1419, 1386, 1356, 1158, 1043, 1015, 803, 746, 726 cm
-1
. 
1
H NMR (CDCl3): δ = 8.78 (m, 1 H, 
pyr-H), 8.25 (m, 1 H, pyr-H), 7.86 (m, 1 H, pyr-H), 7.39 (m, 1 H, pyr-H), 4.70 (t, 2 H, J = 7.1 
Hz, CH2N), 2.10 (m, 2 H, CH2), 1.28 (m, 10 H, CH2), 0.86 (t, 3 H, J = 6.9 Hz, CH3) ppm. 
13
C 
NMR (CDCl3): δ = 164.7 (CN4), 150.3, 146.9, 137.0, 124.7, 122.3, 53.5 (CH2N), 31.6, 29.3, 
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28.9, 28.8 26.2, 22.5, 14.0 ppm. ESI-HRMS: calcd for C14H22N5 [M+1]
+
 260.1870, found 
260.1879. 
 
General coordination reactions  
 
The appropriate tetrazole ligand, L2A-D, L3A-D, L4A-C or L5A-C (0.20 g) was dissolved 
in methanol (30 mL) and was added to a solution of the appropriate metal chloride salt (one 
equivalent) in methanol (25 mL). The resulting strongly-coloured solution was then heated to 
reflux temperature for 2 h before being allowed to stand at room temperature for several days. 
 
[Zn(L2A)Cl2]2 
 
Waxy cream solid (0.17 g, 56 %). C18H20Br2Cl4Zn2N10: calcd. C 26.73, H 2.49, N 17.32; 
found C 26.72, H 2.53, N 16.96. IR (KBr): υ = 2945, 2823, 1610, 1565, 1548, 1453, 1058, 
1015, 850, 770 cm
-1
. 
1
H NMR (CDCl3): δ = 8.78 (m, 1H, pyr-H), 8.35 (m, 1H, pyr-H), 7.95 
(m, 1H, pyr-H), 7.45 (m, 1H, pyr-H), 5.18 (t, 2H, J = 7.0 Hz, CH2N), 3.49 (t, 2H, J = 6.2 Hz, 
CH2Br), 2.18 (m, 2H, CH2) ppm. 
13
C NMR (CDCl3): δ = 157.1 (CN4), 149.5, 148.2, 138.6, 
125.7, 124.9, 49.1 (CH2N), 33.2 (CH2Br), 29.4 ppm. 
 
[Cu(L2A)Cl2]2 
 
Green solid (0.12 g, 40 %). C18H20Br2Cl4Cu2N10: calcd. C 26.85, H 2.50, N 17.40; found C 
27.13, H 2.56, N 17.76. IR (KBr): υ = 2855, 1616, 1484, 1455, 1261, 1167, 1109, 1012, 794, 
745, 718 cm
-1. λmax (MeOH) 856 nm, ε = 59 M
-1
cm
-1
. Magnetic moment: 2.1 B.M. 
 
[Ni(L2A)Cl2]2 
 
Dark green solid (0.12 g, 41 %). C18H20Br2Cl4Ni2N10: calcd. C 27.18, H 2.53, N 17.61; found 
C 26.41, H 3.06, N 16.97. IR (KBr): υ = 2923, 2850, 1614, 1481, 1455, 1297, 1251, 1165, 
1112, 1013, 793, 725 cm
-1. λmax (MeOH) 348 nm, ε = 86 M
-1
cm
-1
. Magnetic moment: 3.2 
B.M. 
 
[Zn(L3A)Cl2]2 
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Waxy orange solid (0.12 g, 40 %). C18H20Br2Cl4Zn2N10: calcd. C 26.73, H 2.49, N 17.32; 
found C 26.32, H 2.67, N 16.60. IR (KBr): υ = 2958, 2848, 1614, 1573, 1546, 1451, 1288, 
1063, 1027, 800, 730 cm
-1
. 
1
H NMR (CDCl3): δ = 8.88 (m, 1H, pyr-H), 8.31 (m, 1H, pyr-H), 
8.16 (m, 1H, pyr-H), 7.60 (m, 1H, pyr-H), 5.01 (t, 2H, J = 6.8 Hz, CH2N), 3.51 (t, 2H, J = 6.0 
Hz, CH2Br), 2.71 (m, 2H, CH2) ppm. 
13
C NMR (CDCl3): δ = 161.8 (CN4), 149.8, 141.8, 
141.1, 128.2, 123.0, 52.3 (CH2N), 40.7 (CH2Br), 31.4 ppm.  
 
[Cu(L3A)Cl2]2 
 
Green solid (0.17 g, 57 %). C18H20Br2Cl4Cu2N10: calcd. C 26.85, H 2.50, N 17.40; found C 
27.66, H 2.47, N 18.34. IR (KBr): υ = 2860, 1619, 1552, 1450, 1267, 1228, 1064, 1021, 804, 
761, 724 cm
-1. λmax (MeOH) 800 nm, ε = 36 M
-1
cm
-1
. Magnetic moment: 2.2 B.M. 
 
[Ni(L3A)Cl2]2 
 
Pale green solid (0.14 g, 48 %). C18H20Br2Cl4Ni2N10: calcd. C 27.18, H 2.53, N 17.61; found 
C 27.64, H 3.06, N 17.69. IR (KBr): υ = 2955, 2853, 1614, 1549, 1452, 1288, 1104, 1026, 
806, 762 cm
-1. λmax (MeOH) 384 nm, ε = 53 M
-1
cm
-1
. Magnetic moment: 3.2 B.M. 
 
[Zn(L2B)Cl2]2 
 
Waxy orange solid (0.17 g, 59 %). C20H24Br2Cl4Zn2N10: calcd. C 28.70, H 2.89, N 16.74; 
found C 28.34, H 2.25, N 16.68. IR (KBr): υ = 2949, 2870, 1610, 1481, 1458, 1441, 1252, 
1168, 1010, 794, 748, 724 cm
-1
. 
1
H NMR (CDCl3): δ = 8.78 (m, 1H, pyr-H), 8.36 (m, 1H, 
pyr-H), 7.96 (m, 1H, pyr-H), 7.50 (m, 1H, pyr-H), 5.02 (t, 2H, J = 7.0 Hz, CH2N), 3.57 (t, 
2H, J = 6.4 Hz, CH2Br), 2.18 (m, 2H, CH2), 1.97 (m, 2H, CH2) ppm. 
13
C NMR (CDCl3): δ = 
159.1 (CN4), 149.5, 147.1, 137.6, 125.4, 124.6, 48.8 (CH2N), 32.5 (CH2Br), 29.2, 29.1 ppm.  
 
[Cu(L2B)Cl2]2 
 
Green solid (0.19 g, 65 %). C20H24Br2Cl4Cu2N10: calcd. C 28.83, H 2.90, N 16.81; found C 
28.21, H 2.15, N 16.41. IR (KBr): υ = 2941, 2851, 1614, 1483, 1456, 1250, 1151, 1012, 791, 
746, 718 cm
-1. λmax (MeOH) 848 nm, ε = 145 M
-1
cm
-
1. Magnetic moment: 2.3 B.M. 
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[Ni(L2B)Cl2]2 
 
Pale green solid (0.15 g, 50 %). C20H24Br2Cl4Ni2N10: calcd. C 29.17, H 2.94, N 17.01; found 
C 28.28, H 3.34, N 16.78. IR (KBr): υ = 2961, 2866, 1613, 1481, 1457, 1252, 1108, 1015, 
794, 725 cm
-1. λmax (MeOH) 376 nm, ε = 40 M
-1
cm
-1
. Magnetic moment: 2.8 B.M. 
 
[Zn(L3B)Cl2]2 
 
Cream solid (0.15 g, 51 %). C20H24Br2Cl4Zn2N10: calcd. C 28.70, H 2.89, N 16.74; found C 
28.37, H 2.92, N 16.20. IR (KBr): υ = 2957, 2870, 1614, 1572, 1548, 1452, 1395, 1285, 
1064, 1028, 800, 753, 729 cm
-1
. 
1
H NMR (CDCl3): δ = 8.96 (m, 1H, pyr-H), 8.29 (m, 1H, 
pyr-H), 8.22 (m, 1H, pyr-H), 7.84 (m, 1H, pyr-H), 4.88 (t, 2H, J = 7.0 Hz, CH2N), 3.47 (t, 
2H, J = 6.2 Hz, CH2Br), 2.33 (m, 2H, CH2), 2.00 (m, 2H, CH2) ppm. 
13
C NMR (CDCl3): δ = 
161.7 (CN4), 149.7, 141.7, 141.3, 128.3, 122.9, 54.6 (CH2N), 43.7 (CH2Br), 32.1, 29.0 ppm. 
 
[Cu(L3B)Cl2]2 
 
Green solid (0.16 g, 55 %). C20H24Br2Cl4Cu2N10: calcd. C 28.83, H 2.90, N 16.81; found C 
29.57, H 2.91, N 17.57. IR (KBr): υ = 2951, 2849, 1617, 1552, 1451, 1259, 1156, 1101, 
1062, 1023, 797, 757, 724 cm
-1. λmax (MeOH) 832 nm, ε = 145 M
-1
cm
-1
. Magnetic moment: 
2.1 B.M. 
 
[Ni(L3B)Cl2]2 
 
Pale green solid (0.14 g, 47 %). C20H24Br2Cl4Ni2N10: calcd. C 29.17, H 2.94, N 17.01; found 
C 28.49, H 3.51, N 16.24. IR (KBr): υ = 2951, 2862, 1613, 1545, 1451, 1391, 1259, 1154, 
1103, 1025, 805, 763 cm
-1. λmax (MeOH) 380 nm, ε = 37 M
-1
cm
-1
. Magnetic moment: 3.6 
B.M. 
 
[Zn(L2C)Cl2]2 
 
Waxy cream solid (0.17 g, 60 %). C24H32Br2Cl4Zn2N10: calcd. C 32.28, H 3.61, N 15.69; 
found C 33.01, H 4.00, N 15.12. IR (KBr): υ = 2931, 2857, 1610, 1543, 1482, 1459, 1249, 
1108, 1010, 793, 724 cm
-1
. 
1
H NMR (CDCl3): δ = 8.92 (m, 1H, pyr-H), 8.29 (m, 1H, pyr-H), 
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8.06 (m, 1H, pyr-H), 7.61 (m, 1H, pyr-H), 4.92 (t, 2H, J = 7.2 Hz, CH2N), 3.42 (t, 2H, J = 6.7 
Hz, CH2Br), 2.02 (m, 2H, CH2), 1.90 (m, 2H, CH2), 1.48 (m, 4H, CH2) ppm. 
13
C NMR 
(CDCl3): δ = 151.5 (CN4), 150.0, 143.3, 138.5, 126.3, 124.6, 62.8 (CH2N), 49.7 (CH2Br), 
33.6, 32.3, 29.3, 27.9 ppm.  
 
[Ni(L2C)Cl2]2 
 
Pale green solid (0.12 g, 42 %). C24H32Br2Cl4Ni2N10: calcd. C 32.77, H 3.67, N 15.92; found 
C 32.65, H 3.74, N 15.88. IR (KBr): υ = 2934, 2853, 1608, 1478, 1457, 1252, 1051, 1012, 
799, 726 cm
-1. λmax (MeOH) 376 nm, ε = 48 M
-1
cm
-1
.Magnetic moment: 3.9 B.M. 
 
[Zn(L3C)Cl2]2 
 
Waxy cream solid (0.14 g, 49 %). C24H32Br2Cl4Zn2N10: calcd. C 32.28, H 3.61, N 15.69; 
found C 32.45, H 3.68, N 15.34. IR (KBr): υ = 2939, 2862, 1614, 1573, 1451, 1287, 1262, 
1063, 1048, 801, 731 cm
-1
. 
1
H NMR (CDCl3): δ = 8.86 (m, 1H, pyr-H), 8.28 (m, 1H, pyr-H), 
8.19 (m, 1H, pyr-H), 7.76 (m, 1H, pyr-H), 4.81 (t, 2H, J = 7.1 Hz, CH2N), 3.41 (t, 2H, J = 6.5 
Hz, CH2Br), 2.16 (m, 2H, CH2), 1.89 (m, 2H, CH2), 1.53 (m, 4H, CH2) ppm. 
13
C NMR 
(CDCl3): δ = 162.5 (CN4), 149.9, 143.2, 140.1, 127.2, 122.7, 54.8 (CH2N), 44.8 (CH2Br), 
32.1, 29.2, 25.5, 25.4 ppm.  
 
[Ni(L3C)Cl2]2 
 
Pale green solid (0.10 g, 35 %). C24H32Br2Cl4Ni2N10: calcd. C 32.77, H 3.67, N 15.92; found 
C 31.12, H 4.16, N 15.52. IR (KBr): υ = 2935, 2823, 1615, 1451, 1261, 1063, 1027, 801, 756, 
731 cm
-1. λmax (MeOH) 376 nm, ε = 92 M
-1
cm
-1
.Magnetic moment: 4.1 B.M. 
 
[Zn(L2D)Cl2]2 
 
Orange oil (0.14 g, 50 %). C28H40Br2Cl4Zn2N102H2O: calcd. C 34.14, H 4.50, N 14.22; 
found C 34.11, H 5.08, N 13.53. IR (film): υ = 2932, 2856, 1654, 1589, 1465, 1390, 1253, 
1119, 798, 744 cm
-1
. 
1
H NMR (CDCl3): δ = 8.76 (m, 1H, pyr-H), 8.32 (m, 1H, pyr-H), 7.97 
(m, 1H, pyr-H), 7.49 (m, 1H, pyr-H), 4.96 (t, 2H, J = 7.3 Hz, CH2N), 3.38 (t, 2H, J = 6.2 Hz, 
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CH2Br), 1.94 (m, 2H, CH2), 1.80 (m, 2H, CH2), 1.32 (m, 8H, CH2) ppm. 
13
C NMR (CDCl3): 
δ = 151.7 (CN4), 149.6, 144.1, 137.9, 125.7, 124.6, 49.7 (CH2N), 37.5 (CH2Br), 32.7, 29.6, 
28.8, 28.5, 27.9, 26.6 ppm.  
 
[Cu(L2D)Cl2]2 
 
Green solid (0.21 g, 75%). C28H40Br2Cl4Cu2N10: calcd. C 35.57, H 4.26, N 14.82; found C 
36.17, H 4.57, N 15.79. IR (KBr): υ = 2932, 2855, 1611, 1481, 1451, 1411, 1289, 1229, 
1162, 1008, 788 cm
-1. λmax (MeOH) 840 nm, ε = 126 M
-1
cm
-1
. Magnetic moment: 2.3 B.M. 
 
[Ni(L2D)Cl2]2 
 
Pale green solid (0.19 g, 70 %). C28H40Br2Cl4Ni2N10: calcd. C 35.94, H 4.31, N 14.97; found 
C 35.82, H 4.39, N 14.81. IR (KBr): υ = 2929, 2856, 1606, 1478, 1459, 1436, 1255, 1105, 
1014, 802, 725 cm
-1. λmax (MeOH) 376 nm, ε = 46 M
-1
cm
-1
. Magnetic moment: 3.9 B.M. 
 
[Zn(L3D)Cl2]2 
 
Cream solid (0.15 g, 53 %). C28H40Br2Cl4Zn2N10: calcd. C 35.43, H 4.25, N 14.76; found C 
34.91, H 4.22, N 14.21. IR (KBr): υ = 2926, 2855, 1613, 1572, 1546, 1453, 1395, 1260, 
1063, 1027, 804, 756, 731 cm
-1
. 
1
H NMR (CDCl3): δ = 8.89 (m, 1H, pyr-H), 8.31 (m, 1H, 
pyr-H), 8.22 (m, 1H, pyr-H), 7.81 (m, 1H, pyr-H), 4.81 (t, 2H, J = 7.1 Hz, CH2N), 3.40 (t, 
2H, J = 6.7 Hz, CH2Br), 2.14 (m, 2H, CH2), 1.85 (m, 2H, CH2), 1.41 (m, 8H, CH2) ppm. 
13
C 
NMR (CDCl3): δ = 161.7 (CN4), 149.8, 142.0, 141.2, 128.1, 122.9, 55.2 (CH2N), 45.1 
(CH2Br), 34.0, 32.4, 28.9, 27.9, 26.6, 26.1 ppm.  
 
[Cu(L3D)Cl2]2 
 
Green solid (0.20 g, 71 %). C28H40Br2Cl4Cu2N10: calcd. C 35.57, H 4.26, N 14.82; found C 
36.17, H 4.42, N 15.19. IR (KBr): υ = 2927, 2851, 1621, 1548, 1449, 1283, 1267, 1227, 
1010, 796, 757 cm
-1. λmax (MeOH) 808 nm, ε = 105 M
-1
cm
-1
. Magnetic moment: 2.4 B.M. 
 
[Ni(L3D)Cl2]2 
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Pale green solid (0.15 g, 55 %). C28H40Br2Cl4Ni2N10: calcd. C 35.94, H 4.31, N 14.97; found 
C 36.26, H 4.90, N 14.28. IR (KBr): υ = 2930, 2857, 1614, 1452, 1259, 1156, 1025, 807, 732 
cm
-1. λmax (MeOH) 384 nm, ε = 194 M
-1
cm
-1
. Magnetic moment: 3.5 B.M. 
 
[Zn(L4A)Cl2]2 
 
Orange solid (0.21 g, 72%). C20H26Cl4Zn2N10H2O: calcd. C 34.44, H 4.05, N 20.09; found C 
34.13, H 4.30, N 19.49. IR (KBr): υ = 2961, 2873, 1609, 1535, 1482, 1459, 1445, 1379, 
1301, 1252, 1168, 1110, 1049, 1012, 800, 753, 725 cm
-1
. 
1
H NMR (CDCl3): δ = 9.00 (m, 1 H, 
pyr-H), 8.21 (m, 1 H, pyr-H), 8.12 (m, 1 H, pyr-H), 7.69 (m, 1 H, pyr-H), 4.86 (t, 2 H, J = 7.3 
Hz, CH2N), 1.98 (m, 2 H, CH2), 1.45 (m, 2 H, CH2), 0.99 (t, 3 H, J = 7.3 Hz, CH3) ppm. 
13
C 
NMR (CDCl3): δ = 150.0 (CN4), 149.1, 145.1, 138.0, 125.8, 124.4, 49.5 (CH2N), 31.7, 19.6, 
13.4 ppm.  
 
 [Cu(L4A)Cl2]2 
 
Green solid (0.17 g, 51 %). C20H26Cl4Cu2N10: calcd. C 35.57, H 3.88, N 20.74; found C 
35.39, H 3.92, N 20.27. IR (KBr): υ = 2961, 2868, 1614, 1546, 1482, 1457, 1437, 1378, 
1251, 1166, 1049, 1003, 719 cm
-1. λmax (MeOH) 836 nm, ε = 110 M
-1
cm
-1
. Magnetic 
moment: 2.1 B.M. 
 
[Ni(L4A)Cl2]2 
 
Green solid (0.29 g, 80 %). C20H26Cl4N10Ni24H2O: calcd. C 32.54, H 4.65, N 18.99; found 
C 32.97, H 4.76, N 19.01. IR (KBr): υ = 2960, 2934, 2873, 1615, 1451, 1393, 1287, 1224, 
1100, 1063, 1027, 802, 758, 732 cm
-1. λmax (MeOH) 392 nm, ε = 25 M
-1
cm
-1
. Magnetic 
moment: 3.2 B.M. 
 
 Co(L4A)2(NCS)2 
 
Green crystalline solid (0.15 g, 53 %). C22H26CoN12S2: calcd. C 45.43, H 4.51, N 28.90; 
found C 46.15, H 3.74, N 28.43. IR (KBr): υ = 2960, 2876, 2068, 1609, 1478, 1456, 1291, 
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1251, 1160, 1045, 1007, 792, 746 cm
-1. λmax (MeOH) 520 nm, ε = 40 M
-1
cm
-1
. Magnetic 
moment: 5.4 B.M. 
 
 [Zn(L5A)Cl2]2 
 
White solid (0.19 g, 66 %). C20H26Cl4Zn2N10: calcd. C 35.37, H 3.86, N 20.63; found C 
34.88, H 3.97, N 20.15. IR (KBr): υ = 2963, 2875, 1614, 1573, 1547, 1453, 1394, 1288, 
1259, 1063, 1046, 1028, 804, 757 cm
-1
. 
1
H NMR (CDCl3): δ = 8.94 (m, 1 H, pyr-H), 8.28 (m, 
1 H, pyr-H), 8.09 (m, 1 H, pyr-H), 7.67 (m, 1 H, pyr-H), 4.75 (t, 2 H, J = 7.2 Hz, CH2N), 2.08 
(m, 2 H, CH2), 1.42 (m, 2 H, CH2), 0.98 (t, 3 H, J = 7.3 Hz, CH3) ppm. 
13
C NMR (CDCl3): δ 
= 161.4 (CN4), 149.8, 141.6, 141.5, 128.3, 122.8, 55.1 (CH2N), 30.9, 19.5, 13.3 ppm. 
 
 [Cu(L5A)Cl2]2 
 
Green solid (0.12 g, 36 %). C20H26Cl4Cu2N10: calcd. C 35.57, H 3.88, N 20.74; found C 
35.63, H 4.05, N 20.45. IR (KBr): υ = 2961, 2880, 1619, 1609, 1552, 1461, 1449, 1352, 
1269, 1100, 1026, 799, 758, 724 cm
-1. λmax (MeOH) 808 nm, ε = 115 M
-1
cm
-1
. Magnetic 
moment: 2.0 B.M. 
 
[Ni(L5A)Cl2]2 
 
Pale green solid (0.20 g, 56 %). C20H26Cl4N10Ni24H2O: calcd. C 32.54, H 4.65, N 18.99; 
found C 32.71, H 4.69, N 18.87. IR (KBr): υ = 2961, 2934, 2873, 1611, 1479, 1457, 1294, 
1254, 1162, 1050, 1010, 795, 752, 727 cm
-1. λmax (MeOH) 392 nm, ε = 19 M
-1
cm
-1
. Magnetic 
moment: 2.9 B.M. 
 
 Co(L5A)2(NCS)2 
 
Rust coloured crystals (0.19 g, 67 %). C22H26CoN12S2: calcd. C 45.43, H 4.51, N 28.90; 
found C 46.99, H 4.30, N 29.56. IR (KBr): υ = 2959, 2873, 2077, 1610, 1458, 1447, 1375, 
1285, 1256, 1153, 1059, 1046, 802, 754 cm
-1. λmax (MeOH) 508 nm, ε = 50 M
-1
cm
-1
. 
Magnetic moment: 5.3 B.M. 
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 [Zn(L4B)Cl2]2 
 
Orange solid (0.30 g, 83 %). C24H34Cl4Zn2N103H2O: calcd. C 36.50, H 5.11, N 17.75; found 
C 36.77, H 5.56, N 17.30. IR (KBr): υ = 2955, 2927, 2856, 1610, 1480, 1460, 1433, 1377, 
1164, 1051, 1013, 796, 747, 724 cm
-1
. 
1
H NMR (CDCl3): δ = 9.04 (m, 1 H, pyr-H), 8.26 (m, 
1 H, pyr-H), 8.20 (m, 1 H, pyr-H), 7.75 (m, 1 H, pyr-H), 4.81 (t, 2 H, J = 7.3 Hz, CH2N), 2.00 
(m, 2 H, CH2), 1.33 (m, 6 H, CH2), 0.86 (t, 3 H, J = 6.9 Hz, CH3) ppm. 
13
C NMR (CDCl3): δ 
= 151.4 (CN4), 150.7, 140.7, 140.2, 128.0, 125.0, 50.6 (CH2N), 31.6, 29.0, 26.3, 22.5, 14.0 
ppm.   
 
 [Cu(L4B)Cl2]2 
 
Green solid (0.11 g, 35 %). C24H34Cl4Cu2N10: calcd. C 39.41, H 4.68, N 19.15; found C 
39.23, H 4.75, N 18.66. IR (KBr): υ = 2955, 2927, 2872, 1611, 1541, 1482, 1455, 1382, 
1112, 1050, 1008, 792, 751, 719 cm
-1. λmax (MeOH) 840 nm, ε = 111 M
-1
cm
-1
. Magnetic 
moment: 2.0 B.M. 
 
[Ni(L4B)Cl2]2 
 
Green solid (0.22 g, 71 %). C24H34Cl4Ni2N104H2O: calcd. C 36.31, H 5.33, N 17.64; found 
C 36.45, H 5.87, N 17.27.  IR (KBr): υ = 2955, 2926, 2856, 1642, 1613, 1479, 1456, 1415, 
1378, 1294, 1253, 1163, 1108, 1012, 796, 752 cm
-1. λmax (MeOH) 404 nm, ε = 31 M
-1
cm
-1
. 
Magnetic moment: 3.2 B.M. 
 
 Co(L4B)2(NCS)2 
 
Green crystalline solid (0.18 g, 66 %). C26H34CoN12S2: calcd. C 48.97, H 5.37, N 26.36; 
found C 49.48, H 6.21, N 25.88. IR (KBr): υ = 2925, 2854, 2067, 1609, 1476, 1456, 1293, 
1106, 1008, 793, 745, 725 cm
-1. λmax (MeOH) 520 nm, ε = 56 M
-1
cm
-1
. Magnetic moment: 
5.1 B.M. 
 
 [Zn(L5B)Cl2]2 
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White solid (0.26 g, 72 %). C24H34Cl4Zn2N10 2CH3OH: calcd. C 39.05, H 5.30, N 17.53; 
found C 38.18, H 5.30, N 16.81. IR (KBr): υ = 2925, 2855, 1653, 1613, 1573, 1547, 1454, 
1395, 1286, 1260, 1161, 1102, 1063, 1046, 1027, 804, 756, 731 cm
-1
. 
1
H NMR (CDCl3): δ = 
9.02 (m, 1 H, pyr-H), 8.34 (m, 1 H, pyr-H), 8.16 (m, 1 H, pyr-H), 7.92 (m, 1 H, pyr-H), 4.82 
(t, 2 H, J = 7.1 Hz, CH2N), 2.12 (m, 2 H, CH2), 1.32 (m, 6 H, CH2), 0.87 (t, 3 H, J = 7.1 Hz, 
CH3) ppm. 
13
C NMR (CDCl3): δ = 161.1 (CN4), 149.7, 142.0, 141.3, 128.7, 123.0, 55.5 
(CH2N), 31.6, 28.8, 26.2, 22.5, 14.0 ppm.  
 
 [Cu(L5B)Cl2]2 
 
Green solid (0.12 g, 38 %). C24H34Cl4Cu2N10: calcd. C 39.41, H 4.68, N 19.15; found C 
39.20, H 4.76, N 18.87. IR (KBr): υ = 2953, 2925, 2858, 1617, 1551, 1450, 1354, 1284, 
1103, 1025, 801, 757, 726 cm
-1. λmax (MeOH) 812 nm, ε = 129 M
-1
cm
-1
. Magnetic moment: 
2.0 B.M. 
 
[Ni(L5B)Cl2]2 
 
Green solid (0.29 g, 93 %). C24H34Cl4Ni2N10 4H2O: calcd. C 36.31, H 5.33, N 17.64; found 
C 36.85, H 5.23, N 16.84. IR (KBr): υ = 2954, 2926, 2856, 1614, 1452, 1392, 1354, 1286, 
1261, 1225, 1157, 1100, 1047, 1063, 1026, 804, 759, 732 cm
-1. λmax (MeOH) 400 nm, ε = 17 
M
-1
cm
-1
. Magnetic moment: 4.3 B.M. 
 
 Co(L5B)2(NCS)2 
 
Rust coloured crystals (0.17 g, 63 %). C26H34CoN12S2CH3OH: calcd. C 48.42, H 5.72, N 
25.11; found C 48.80, H 6.02, N 24.28. IR (KBr): υ = 2922, 2852, 2074, 1609, 1459, 1447, 
1372, 1154, 1099, 1046, 1025, 802, 756 cm
-1. λmax (MeOH) 508 nm, ε = 49 M
-1
cm
-1
. 
Magnetic moment: 4.0 B.M. 
 
[Zn(L4C)Cl2]2 
 
Orange solid (0.20 g, 86 %). C28H42Cl4Zn2N10 4H2O: calcd. C 38.93, H 5.84, N 16.23; found 
C 37.95, H 5.78, N 15.25. IR (KBr): υ = 2955, 2927, 2856, 1610, 1481, 1460, 1377, 1297, 
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1051, 1012, 795, 747, 724 cm
-1
. 
1
H NMR (CDCl3): δ = 9.11 (m, 1 H, pyr-H), 8.18 (m, 2 H, 
pyr-H), 7.76 (m, 1 H, pyr-H), 4.78 (t, 2 H, J = 7.3 Hz, CH2N), 2.02 (m, 2 H, CH2), 1.32 (m, 
10 H, CH2), 0.88 (t, 3 H, J = 6.9 Hz, CH3) ppm. 
13
C NMR (CDCl3): δ = 151.2 (CN4), 151.1, 
141.7, 138.8, 128.7, 125.2, 50.8 (CH2N), 31.6, 29.0, 28.9, 28.8, 26.4, 22.6, 14.0 ppm.  
 
 [Cu(L4C)Cl2]2 
 
Green solid (0.13 g, 43 %). C28H42Cl4Cu2N10: calcd. C 42.70, H 5.37, N 17.78; found C 
41.66, H 5.39, N 17.53. IR (KBr): υ = 2955, 2924, 2857, 1611, 1540, 1482, 1446, 1384, 
1113, 1049, 1007, 792, 748, 719 cm
-1. λmax (MeOH) 832 nm, ε = 114 M
-1
cm
-1
. Magnetic 
moment: 1.8 B.M. 
 
[Ni(L4C)Cl2]2 
 
Green solid (0.18 g, 60 %). C28H42Cl4Ni2N104H2O: calcd. C 39.55, H 5.93, N 16.48; found 
C 39.08, H 5.41, N 15.65. IR (KBr): υ = 2955, 2925, 2855, 1611, 1479, 1456, 1377, 1254, 
1162, 1049, 1012, 797, 752 cm
-1. λmax (MeOH) 396 nm, ε = 455 M
-1
cm
-1
. Magnetic moment: 
4.2 B.M. 
 
 Co(L4C)2(NCS)2 
 
Orange crystalline solid (0.15 g, 58 %). C30H42CoN12S2: calcd. C 51.93, H 6.10, N 24.23; 
found C 51.23, H 5.40, N 24.14. IR (KBr): υ = 2925, 2854, 2068, 1610, 1476, 1457, 1412, 
1161, 1010, 789, 725 cm
-1. λmax (MeOH) 516 nm, ε = 55 M
-1
cm
-1
. Magnetic moment: 6.7 
B.M. 
 
 [Zn(L5C)Cl2]2 
 
White solid (0.16 g, 70 %). C28H42Cl4Zn2N10: calcd. C 42.50, H 5.35, N 17.70; found C 
42.86, H 6.23, N 18.35. IR (KBr): υ = 2926, 2854, 1610, 1571, 1543, 1452, 1393, 1285, 
1259, 1158, 1099, 1061, 1045, 1025, 805, 757, 732 cm
-1
. 
1
H NMR (CDCl3): δ = 8.87 (m, 1 H, 
pyr-H), 8.28 (m, 1 H, pyr-H), 8.11 (m, 1 H, pyr-H), 7.69 (m, 1 H, pyr-H), 4.76 (t, 2 H, J = 7.2 
Hz, CH2N), 2.10 (m, 2 H, CH2), 1.30 (m, 10 H, CH2), 0.88 (t, 3 H, J = 6.8 Hz, CH3) ppm. 
13
C 
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NMR (CDCl3): δ = 162.3 (CN4), 149.9, 143.2, 140.1, 127.2, 122.6, 54.8 (CH2N), 31.6, 29.1, 
28.9, 28.7 26.2, 22.5, 14.0 ppm. 
 
 [Cu(L5C)Cl2]2 
 
Green solid (0.10 g, 33 %). C28H42Cl4Cu2N10: calcd. C 42.70, H 5.37, N 17.78; found C 
43.61, H 5.39, N 17.24. IR (KBr): υ = 2955, 2923, 2850, 1616, 1537, 1466, 1454, 1432, 
1360, 1285, 1158, 1014, 801, 765, 726 cm
-1. λmax (MeOH) 812 nm, ε = 86 M
-1
cm
-1
. Magnetic 
moment: 2.2 B.M. 
 
 [Ni(L5C)Cl2]2 
 
Pale green solid (0.21 g, 70 %). C28H42Cl4Ni2N102H2O: calcd. C 41.30, H 5.70, N 17.21; 
found C 41.05, H 6.11, N 17.25. IR (KBr): υ = 2955, 2925, 2855, 1615, 1452, 1392, 1286, 
1262, 1226, 1101, 1047, 1063, 1027, 802, 758, 732 cm
-1. λmax (MeOH) 396 nm, ε = 21 M
-
1
cm
-1
. Magnetic moment: 4.4 B.M. 
 
Co(L5C)2(NCS)2 
 
Rust coloured crystals (0.13 g, 50 %). C30H42CoN12S2: calcd. C 51.93, H 6.10, N 24.23; 
found C 51.47, H 6.11, N 24.09. IR (KBr): υ = 2923, 2852, 2074, 1609, 1541, 1447, 1389, 
1258, 1154, 1099, 1046, 1024, 801, 756 cm
-1. λmax (MeOH) 508 nm, ε = 50 M
-1
cm
-1
. 
Magnetic moment: 5.1 B.M. 
 
X-ray structure determination 
 
Single-crystal X-ray data for both Co(L5A)2(NCS)2 and Co(L5C)2(NCS)2 were collected on 
an Oxford Diffraction Gemini-S Ultra diffractometer at 294(1) K, with  range 2-25º 
minimum and 100% data coverage to 25º (on ) [14]. Data reduction procedures and 
absorption corrections are standard [14]; comprehensive details have been published 
elsewhere [15]. All structures were solved using the SHELXS97 [16] direct methods program 
and refined by full matrix least squares calculations on F
2
 with all non-hydrogen atoms 
having anisotropic displacement parameters. Hydrogen atoms were treated as riding atoms 
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using the SHELXS97 defaults at 294(1) K using the OSCAIL software [17]. Selected 
crystallographic and structural information are detailed in Table 3 and the ESI. Molecular 
diagrams (Figures 2 and 3) were generated using PLATON [18]. All searches and analyses of 
the Cambridge Structural Database (CSD) were performed with the November 2011 release 
(version 5.33) [19,20].  
 
The Co(L5A)2(NCS)2 structure refined without any problems although the six C atoms C22-
C24 and C42-C44 were treated with moderate DFIX/DELU/SIMU restraints. The 
Co(L5C)2(NCS)2 structure exhibits considerable disorder and librational motion along the n-
octyl chain (Figure 3) and primarily in the mid-part (this was treated using two separate sites 
for C31A/B and C32A/B and moderate DFIX restraints so as to give satisfactory results). 
Disorder in long chain n-alkyl groups is not uncommon in structural chemistry and with large 
displacement parameters associated with the carbon atoms. The refinements of 
Co(L5A)2(NCS)2 and Co(L5C)2(NCS)2 converged at 5.2% and 8.0% respectively. 
 
CCDC reference codes 898052 and 898053. Copies available, e-mail: 
deposit@ccdc.cam.ac.uk.   
 
Conclusions 
 
In this follow-on paper from the X-ray crystallographic study of 2-(2H-tetrazol-5-yl)pyridine 
derivatives containing a 6-bromohexyl pendant arm [10], 2-(2H-tetrazol-5-yl)pyridine 
derivatives containing either an n-bromoalkyl pendant arm (n = 3, 4, 6, 8) or an n-alkyl chain 
(R = butyl, hexyl or octyl) at either the 1-N or 2-N position of the tetrazole ring were 
synthesised. Their complexation reactions with several M(II) chloride complexes (M = Cu, 
Ni, Zn) and also Co(NCS)2 were studied. In all cases, the pyridyl-tetrazole ligand coordinates 
with the metal ion in a bidentate fashion through the pyridine N atom and the 1-N atom of the 
tetrazole ring. The notable difference between the various complexes is that, in the case of the 
cobalt complexes, the metal:ligand stoichiometry is 1:2 while in all the metal chloride 
complexes it is 1:1. The X-ray structure determination of two cobalt complexes 
Co(L5A)2(NCS)2 and Co(L5C)2(NCS)2 confirmed this. The 
1
H NMR spectra of the zinc 
complexes showed that the ligands containing the pendant arm in the 2-N position of the 
tetrazole ring (L3A-D) bind the zinc ion more strongly than those containing the pendant arm 
in the 1-N position (L2A-D).  
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